KEAM 2026 Registration Opens for BPharm Admissions in Kerala Written By Parthika Patel8 Jan 2026 3:00 PM ISTThiruvananthapuram: The Commissioner for Entrance Examinations (CEE), Kerala, has commenced the KEAM 2026 registration process for candidates seeking...
Cipla Partner Pharmathen Receives 9 USFDA Observations Written By Farhat Nasim7 Jan 2026 8:22 PM ISTCipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
JB Chemicals to Infuse Up to Rs 18 Crore into Dubai Arm Unique Pharma Labs Written By Farhat Nasim7 Jan 2026 4:54 PM IST"The additional investment in equity shares of UPL FZE would be utilized towards operational requirements of UPL FZE," the company said.
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs Written By Parthika Patel7 Jan 2026 4:37 PM ISTThese products are among the largest oncology biologics expected to lose exclusivity over the next five years.
Export Council PHARMEXCIL Holds Strategic Talks with Govt on Scaling USD 30.47 Billion Pharma Exports Written By sheeba farhat7 Jan 2026 4:27 PM ISTPHARMEXCIL engaged senior Commerce and Pharma Ministry officials to align policy, boost MSME participation, and sustain India's 9.4% pharma export...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs Written By sheeba farhat7 Jan 2026 4:11 PM ISTNimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to develop an easy-to-take oral...
Novo Nordisk's US Public Affairs Head Jennifer Duck Exits Amid Pricing Pressure, Obesity Drug Battle Written By sheeba farhat7 Jan 2026 4:04 PM ISTCEO Doustdar is trying to restore investor confidence by sharpening Novo's focus, after a tough year in which the company issued multiple profit...
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal Written By sheeba farhat7 Jan 2026 3:52 PM ISTA potential buyout of Ventyx will add drugs for inflammatory bowel diseases such as Crohn's disease and ulcerative colitis to Lilly's pipeline,...
RUHS Declares D Pharmacy Results 2025, Scorecards Now Available Online Written By Parthika Patel7 Jan 2026 3:46 PM ISTJaipur: The Rajasthan University of Health Sciences (RUHS) has announced the D Pharmacy examination results for 2025, marking an important academic...
Biocon Employee Passes Away in Suspected Workplace Suicide Written By Farhat Nasim6 Jan 2026 4:54 PM ISTBengaluru: In a tragic incident, a 26-year-old employee of Biocon Biologics Limited died after allegedly falling from the fifth floor of the company's...
Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts Written By Susmita Roy6 Jan 2026 4:34 PM ISTNew Delhi: Amid international advisories cautioning travelers to India over reports of a counterfeit anti-rabies vaccine, Indian Immunologicals...
Biocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors Written By Farhat Nasim6 Jan 2026 3:48 PM ISTBengaluru: Biocon Limited has allotted shares to Mylan Inc., giving the US-based company a 6.10% stake in Biocon's paid-up share capital through a...
